1. P776: A PHASE 2, OPEN-LABEL, ASCENDING DOSE STUDY OF KER-050 FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH VERY LOW, LOW, OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES. (23rd June 2022) Authors: Tan, S.; Arbelaez, A.; Chee, L.; Fong, C. Y.; Hiwase, D.; Kannourakis, G.; Kwan, J.; Liang, J.; Puliyayil, A.; Rose, H.; Ross, D.; Teh, T.-C.; Westerman, D.; Wight, J.; Feng, W.; Lachey, J.; McGinty, A.; Natarajan, H.; Rovaldi, C.; Cooper, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗